ENDRA Life Sciences (NDRA) Cash from Operations (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Cash from Operations of 1119650.0 for Q1 2026, up 13.42% year-over-year from 987211.23 in Q1 2025, and up 30.53% quarter-over-quarter from 1611711.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Cash from Operations (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Cash from Operations for 11 consecutive years, with 1119650.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 13.42% year-over-year to 1119650.0; the TTM figure through Mar 2026 stood at 5009079.0 (up 23.52% YoY), while the FY2025 annual figure was 5182558.0, up 29.97% from the prior year.
- Cash from Operations improved to 1119650.0 in Q1 2026 per NDRA's latest filing, from 1611711.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1113715.0 in Q2 2025 and bottomed at 3334982.0 in Q2 2022.
- Historically, Cash from Operations has averaged 2118876.53 across 5 years, with a median of 2144312.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Operations slipped 19.13% — and 2025, when it jumped 46.54%.
- ENDRA Life Sciences' Cash from Operations stood at 3088689.0 in 2022, then advanced by 29.6% to 2174578.0 in 2023, then jumped by 30.3% to 1515705.0 in 2024, then decreased by 6.33% to 1611711.0 in 2025, then surged by 30.53% to 1119650.0 in 2026.
- Business Quant data shows NDRA's Cash from Operations at 1119650.0 in Q1 2026, 1611711.0 in Q4 2025, and 1164003.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 2.13 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.53 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 54.79 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 277.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 347.16 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 201.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 310.42 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 445.50 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | -927,560.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -927,560.00 |
| Jun 30, 2026 | -927,560.00 |
| Mar 31, 2026 | -1.12 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Sep 30, 2025 | -1.16 Mn |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | -2.08 Mn |
| Mar 31, 2024 | -2.14 Mn |
| Mar 31, 2024 | -2.14 Mn |